Speaker 1: Bloomberg Audio Studios, podcasts, radio News, The.
Speaker 2: Stock Movers report, your roundup of companies making moves in
Speaker 2: the stock market, harnessing the power of Bloomberg data.
Speaker 3: Let's take a look at some of the stocks on
Speaker 3: the move today on Paul Sweeney alongside Scarlatfu and we're
Speaker 3: joined by.
Speaker 4: Bloomberg's Bailey Lipshaltz Billybody looking up.
Speaker 3: Yeah, some of the best performing stocks in the S
Speaker 3: and P five hundred this morning are in the airline space.
Speaker 3: This comes after Delta Air ticker dl reported earnings that
Speaker 3: beat expectations and kind of talked up guidance for fourth
Speaker 3: quarter and some of the strength they expect to continue
Speaker 3: to see into twenty twenty six. So Delta Air shares
Speaker 3: up about five and a half percent. Also keeping eye,
Speaker 3: as I mentioned, United Health or United Airlines excuse me,
Speaker 3: up close to four percent.
Speaker 4: Alaska Air trading higher.
Speaker 3: So this comes after management a bit more optimistic not
Speaker 3: only on business demand but broader travel spending, saying that
Speaker 3: they expect to see potentially a record fourth quarter for
Speaker 3: the company.
Speaker 4: People travel for holidays.
Speaker 3: But also a thing to keep in mind, as Bloomberg
Speaker 3: had reported earlier this morning, we're starting to see some
Speaker 3: of those cracks showing up with the government shutdown, what
Speaker 3: that means for the FAA and how that could impact it.
Speaker 3: So management was asked about that, basically saying that, you know,
Speaker 3: if this is extended, that could impact fourth quarter demand,
Speaker 3: but for now they're not really seeing.
Speaker 1: That show up absolutely all right, So Delta a clear
Speaker 1: winner here. You're also keeping an eye on the pharmer space,
Speaker 1: and there's some M and a yeah, m.
Speaker 3: And a Novo Nordisk acquiring a Caro Therapeutics. So Novo
Speaker 3: ADRs ticker ENVO down about one percent and a care
Speaker 3: of Therapeutics up more than sixteen percent, trading about fifty
Speaker 3: four dollars, So this is a four point seven billion
Speaker 3: dollars deal that could be bumped up if the company's
Speaker 3: drug is successful. So not only is there a fifty
Speaker 3: four dollars cash component, there's also a contingent value right Basically,
Speaker 3: Novo Nordisk trying to build out its weight loss opportunities.
Speaker 3: A Caro is not in the weight loss space, but
Speaker 3: treating the deadly liver disease is mash, not the TV show,
Speaker 3: So this is something that could build out their portfolio.
Speaker 3: Again looking through some of the quick analyst reactions, basically
Speaker 3: saying Novo has a lot of wood to chop to
Speaker 3: try to get back to where it was trading before.
Speaker 3: Management talking up this acquisition saying that they want to
Speaker 3: be able to treat not only the weight loss space,
Speaker 3: but also other issues related to the liver fatty liver
Speaker 3: as well.
Speaker 1: Yeah, I'm looking at this and apparently MASH is one
Speaker 1: of the most prevalent obesity related to comorbidities to so
Speaker 1: you know, it's rounding outs portfolio in a very interesting
Speaker 1: holistic way.
Speaker 4: It all fits into that argument.
Speaker 3: And really this does come after Novo's drug that they
Speaker 3: were developing and the space failed, so this is kind
Speaker 3: of trying to replace that. As we see again, not
Speaker 3: only are some of the shot weight loss shots we
Speaker 3: go vi ozepic being pretty successful, there is uncertainty again
Speaker 3: with potential pills and also once those things lose their patents,
Speaker 3: so trying to stay ahead of the game and trying
Speaker 3: to build it out. This again, according to analyst expectations,
Speaker 3: could be a billions upon billions of dollars of potential revenue,
Speaker 3: so a big purchase for Novo Nordice. But again just
Speaker 3: a small kind of step in the direction.
Speaker 4: For the company. All Right, one more Walkware. Yeah, keep
Speaker 4: an eye on MP materialsticker.
Speaker 3: MP up about five percent, seeing a rally across US
Speaker 3: listed rare earth and critical mineral stocks. This comes after
Speaker 3: reports that China is going to apply a default ban
Speaker 3: on defense sector exports of those materials, so investors piling
Speaker 3: into companies that are tied to the US government trying
Speaker 3: to secure some of those non China supply chains for
Speaker 3: rare earths.
Speaker 2: The Stock Movers report from Bloomberg Radio. Check back with
Speaker 2: us throughout the day for the latest roundup of companies
Speaker 2: making news on Wall Street and for the latest market
Speaker 2: moving headlines. Listen to Bloomberg Radio Live. Catch us on YouTube,
Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with
Speaker 2: the Bloomberg Business app.